ANRO logo

Alto Neuroscience (ANRO) Financials

Balance sheets

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 202301 June 202301 Mar 202301 Dec 2022

Total Assets

$191.6 M(-2.9%)$197.4 M(-6.0%)$209.9 M(+142.3%)$86.6 M(+62.7%)$53.2 M--$50.9 M

Current Assets

$183.5 M(-6.1%)$195.4 M(-6.2%)$208.3 M(+143.9%)$85.4 M(+64.1%)$52.0 M--$49.2 M

Non Current Assets

$8.1 M(+315.3%)$1.9 M(+20.7%)$1.6 M(+30.3%)$1.2 M(+4.1%)$1.2 M--$1.6 M

Total Liabilities

$26.6 M(+51.0%)$17.6 M(+4.5%)$16.8 M(-89.4%)$158.3 M(+38.5%)$114.3 M--$89.3 M

Current Liabilities

$14.0 M(+42.4%)$9.8 M(+22.9%)$8.0 M(+42.7%)$5.6 M(-6.2%)$6.0 M--$5.6 M

Long Term Liabilities

$12.5 M(+62.0%)$7.7 M(-12.2%)$8.8 M(-94.2%)$152.7 M(+40.9%)$108.4 M--$83.7 M

Shareholders Equity

$165.1 M(-8.2%)$179.8 M(-6.9%)$193.1 M(+369.4%)-$71.7 M(-17.3%)-$61.1 M---$38.4 M

Book Value

$165.1 M(-8.2%)$179.8 M(-6.9%)$193.1 M(+369.4%)-$71.7 M(-17.3%)-$61.1 M---$38.4 M

Working Capital

$169.5 M(-8.7%)$185.6 M(-7.4%)$200.3 M(+151.1%)$79.8 M(+73.2%)$46.1 M--$43.7 M

Cash And Cash Equivalents

$181.7 M(-5.9%)$193.1 M(-6.2%)$205.9 M(+149.4%)$82.5 M(+61.0%)$51.3 M--$48.3 M

Accounts Payable

$2.3 M(+22.2%)$1.8 M(-23.6%)$2.4 M(+124.6%)$1.1 M(-38.8%)$1.8 M--$1.6 M

Accounts Receivable

----$8000.0--$333.0 K

Short Term Debt

$4.2 M(+83.2%)$2.3 M(+92.9%)$1.2 M(+860.8%)$125.0 K(-36.9%)$198.0 K--$283.0 K

Long Term Debt

$12.5 M(+62.0%)$7.7 M(-12.2%)$8.8 M(-10.6%)$9.9 M(+1.1%)$9.8 M--$9.5 M

Total Debt

$16.8 M(+66.9%)$10.1 M(+0.5%)$10.0 M(+0.3%)$10.0 M(+0.3%)$10.0 M(+100.0%)$0.0(0%)$0.0(-100.0%)$9.7 M

Debt To Equity

0.1(+66.7%)0.1(+20.0%)0.1(+135.7%)-0.1(+12.5%)-0.2---0.3

Current Ratio

13.1(-34.1%)19.9(-23.7%)26.0(+71.0%)15.2(+74.9%)8.7--8.8

Quick Ratio

--------

Inventory

--------

Retained Earnings

-$123.2 M(-15.8%)-$106.4 M(-17.7%)-$90.4 M(-17.4%)-$77.0 M(-17.1%)-$65.7 M---$40.7 M

PB Ratio

1.9(+13.3%)1.6(-22.9%)2.1-----

Income statements

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 202301 June 202301 Mar 202301 Dec 2022

EPS

-$0.6(-3.3%)-$0.6(+21.1%)-$0.8(-73.3%)-$0.4(-22.7%)-$0.4(-5.5%)-$0.3(+39.6%)-$0.6(+4.8%)-$0.6

TTM EPS

-$2.4(-12.2%)-$2.2(-13.8%)-$1.9(-11.7%)-$1.7(+8.2%)-$1.8(-24.0%)-$1.5(-29.4%)-$1.2(-95.2%)-$0.6

Revenue

--------

TTM Revenue

--------

Total Expenses

$18.9 M(+3.0%)$18.3 M(+27.5%)$14.4 M(+22.3%)$11.8 M(+21.1%)$9.7 M(+6.5%)$9.1 M(+26.7%)$7.2 M(-10.3%)$8.0 M

Operating Expenses

$18.9 M(+3.0%)$18.3 M(+27.5%)$14.4 M(+22.3%)$11.8 M(+21.1%)$9.7 M(+6.5%)$9.1 M(+26.7%)$7.2 M(-10.3%)$8.0 M

Cost Of Goods Sold

--------

TTM Cost Of Goods Sold

--------

Gross Profit

--------

TTM Gross Profit

--------

Gross Margin

--------

Operating Profit

-$18.9 M(-3.0%)-$18.3 M(-27.5%)-$14.4 M(-22.3%)-$11.8 M(-21.1%)-$9.7 M(-6.5%)-$9.1 M(-26.7%)-$7.2 M(+10.3%)-$8.0 M

TTM Operating Profit

-$63.4 M(-16.9%)-$54.2 M(-20.5%)-$45.0 M(-19.0%)-$37.8 M(-11.0%)-$34.1 M(-39.9%)-$24.4 M(-59.9%)-$15.2 M(-89.7%)-$8.0 M

Operating Margin

--------

Net Income

-$16.8 M(-4.7%)-$16.0 M(-19.5%)-$13.4 M(-19.6%)-$11.2 M(-22.7%)-$9.1 M(-5.5%)-$8.7 M(-18.9%)-$7.3 M(+4.8%)-$7.7 M

TTM Net Income

-$57.4 M(-15.3%)-$49.8 M(-17.4%)-$42.4 M(-16.9%)-$36.3 M(-10.9%)-$32.7 M(-38.7%)-$23.6 M(-58.0%)-$14.9 M(-95.2%)-$7.7 M

Net Margin

--------

EBIT

-$16.4 M(-4.8%)-$15.7 M(-20.0%)-$13.1 M(-20.4%)-$10.9 M(-23.7%)-$8.8 M(-5.3%)-$8.3 M(-19.8%)-$7.0 M(+9.0%)-$7.7 M

TTM EBIT

-$56.0 M(-15.8%)-$48.4 M(-17.9%)-$41.0 M(-17.5%)-$34.9 M(-10.1%)-$31.7 M(-38.3%)-$22.9 M(-57.0%)-$14.6 M(-91.0%)-$7.7 M

EBITDA

-$16.3 M(-4.8%)-$15.6 M(-20.0%)-$13.0 M(-20.7%)-$10.7 M(-23.3%)-$8.7 M(-6.0%)-$8.2 M(-19.6%)-$6.9 M(+9.0%)-$7.6 M

TTM EBITDA

-$55.6 M(-15.8%)-$48.0 M(-18.1%)-$40.7 M(-17.6%)-$34.6 M(-10.2%)-$31.4 M(-38.5%)-$22.7 M(-57.0%)-$14.4 M(-91.0%)-$7.6 M

Selling, General & Administrative Expenses

$5.8 M(+13.0%)$5.2 M(+16.3%)$4.4 M(+109.0%)$2.1 M(+21.2%)$1.8 M(-14.7%)$2.1 M(+29.0%)$1.6 M(-8.3%)$1.7 M

TTM SG&A

$17.5 M(+30.3%)$13.5 M(+30.0%)$10.4 M(+37.8%)$7.5 M(+5.4%)$7.1 M(+32.5%)$5.4 M(+61.7%)$3.3 M(+91.7%)$1.7 M

Depreciation And Amortization

$122.0 K(+8.0%)$113.0 K(+16.5%)$97.0 K(-13.4%)$112.0 K(+77.8%)$63.0 K(-43.8%)$112.0 K(+30.2%)$86.0 K-

TTM D&A

$444.0 K(+15.3%)$385.0 K(+0.3%)$384.0 K(+3.0%)$373.0 K(+42.9%)$261.0 K(+31.8%)$198.0 K(+130.2%)$86.0 K-

Interest Expense

$349.0 K(+0.6%)$347.0 K(+0.3%)$346.0 K(-2.8%)$356.0 K(-1.9%)$363.0 K(+11.0%)$327.0 K(+0.9%)$324.0 K(+100.0%)$0.0

TTM Interest Expense

$1.4 M(-1.0%)$1.4 M(+1.4%)$1.4 M(+1.6%)$1.4 M(+35.1%)$1.0 M(+55.8%)$651.0 K(+100.9%)$324.0 K(+100.0%)$0.0

Income Tax

--------

TTM Income Tax

--------

PE Ratio

--------

PS Ratio

--------

Cashflow statements

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 202301 June 202301 Mar 202301 Dec 2022

Cash From Operations

-$11.7 M(-0.3%)-$11.7 M(-6.5%)-$11.0 M(+4.7%)-$11.5 M(-48.4%)-$7.8 M(-17.0%)-$6.6 M(+11.8%)-$7.5 M-

TTM CFO

-$45.9 M(-9.4%)-$42.0 M(-13.7%)-$36.9 M(-10.3%)-$33.4 M(-52.6%)-$21.9 M(-54.8%)-$14.2 M(-88.2%)-$7.5 M-

Cash From Investing

-$1.0 M(-195.6%)-$340.0 K(-51.8%)-$224.0 K(+36.4%)-$352.0 K(-718.6%)-$43.0 K(+20.4%)-$54.0 K(-157.1%)-$21.0 K-

TTM CFI

-$1.9 M(-100.3%)-$959.0 K(-42.5%)-$673.0 K(-43.2%)-$470.0 K(-298.3%)-$118.0 K(-57.3%)-$75.0 K(-257.1%)-$21.0 K-

Cash From Financing

$1.3 M(+662.8%)-$234.0 K(-100.2%)$134.6 M(+212.0%)$43.1 M(+87924.5%)$49.0 K(+196.1%)-$51.0 K(-100.2%)$25.0 M-

TTM CFF

$178.8 M(+0.7%)$177.5 M(-0.1%)$177.7 M(+160.8%)$68.1 M(+172.5%)$25.0 M(+0.2%)$24.9 M(-0.2%)$25.0 M-

Free Cash Flow

-$12.7 M(-5.8%)-$12.0 M(-7.4%)-$11.2 M(+5.6%)-$11.9 M(-52.1%)-$7.8 M(-16.7%)-$6.7 M(+11.3%)-$7.5 M-

TTM FCF

-$47.8 M(-11.5%)-$42.9 M(-14.2%)-$37.6 M(-10.8%)-$33.9 M(-53.9%)-$22.0 M(-54.9%)-$14.2 M(-88.7%)-$7.5 M-

CAPEX

--------

TTM CAPEX

--------

Dividends Paid

--------

TTM Dividends Paid

--------

TTM Dividend Per Share

--------

TTM Dividend Yield

--------

Payout Ratio

--------